Table 2.
Multivariate Cox regression analysis for miR-421 expression in patients with NSCLC
| Characteristics | Multivariate analysis
|
||
|---|---|---|---|
| HR | 95% CI | P | |
| miR-421 (Low vs High) | 1.991 | 1.046–3.791 | 0.036 |
| Age (≤60 years vs >60 years) | 1.364 | 0.746–2.496 | 0.313 |
| Gender (Female vs Male) | 1.092 | 0.618–1.930 | 0.762 |
| Smoking history (No vs Yes) | 1.026 | 0.563–1.869 | 0.934 |
| Tumor size (≤60 cm vs >60 cm) | 1.038 | 0.562–1.920 | 0.904 |
| Lymph-node metastasis (Negative vs Positive) | 1.020 | 0.557–1.868 | 0.949 |
| Differentiation (Good/moderate vs Poor) | 1.243 | 0.686–2.252 | 0.474 |
| TNM stage (I–II vs III–IV) | 1.631 | 0.918–2.898 | 0.095 |
Abbreviations: miR-421, microRNA-421; NSCLC, non-small-cell lung cancer.